Literature DB >> 22872676

Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism.

Volodymyr Tryndyak1, Aline de Conti, Tetyana Kobets, Kristy Kutanzi, Igor Koturbash, Tao Han, James C Fuscoe, John R Latendresse, Stepan Melnyk, Svitlana Shymonyak, Leonard Collins, Sharon A Ross, Ivan Rusyn, Frederick A Beland, Igor P Pogribny.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a major health problem and a leading cause of chronic liver disease in the United States and developed countries. In humans, genetic factors greatly influence individual susceptibility to NAFLD. The goals of this study were to compare the magnitude of interindividual differences in the severity of liver injury induced by methyl-donor deficiency among individual inbred strains of mice and to investigate the underlying mechanisms associated with the variability. Feeding mice a choline- and folate-deficient diet for 12 wk caused liver injury similar to NAFLD. The magnitude of liver injury varied among the strains, with the order of sensitivity being A/J ≈ C57BL/6J ≈ C3H/HeJ < 129S1/SvImJ ≈ CAST/EiJ < PWK/PhJ < WSB/EiJ. The interstrain variability in severity of NAFLD liver damage was associated with dysregulation of genes involved in lipid metabolism, primarily with a down-regulation of the peroxisome proliferator receptor α (PPARα)-regulated lipid catabolic pathway genes. Markers of oxidative stress and oxidative stress-induced DNA damage were also elevated in the livers but were not correlated with severity of liver damage. These findings suggest that the PPARα-regulated metabolism network is one of the key mechanisms determining interstrain susceptibility and severity of NAFLD in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872676      PMCID: PMC3475259          DOI: 10.1096/fj.12-209569

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

Review 1.  The role of oxidative stress in non-alcoholic steatohepatitis.

Authors:  G H Koek; P R Liedorp; A Bast
Journal:  Clin Chim Acta       Date:  2011-04-16       Impact factor: 3.786

2.  Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet.

Authors:  Satomi Nishikawa; Jiro Sugimoto; Miyoko Okada; Tetsuya Sakairi; Shiro Takagi
Journal:  Toxicol Pathol       Date:  2011-11-21       Impact factor: 1.902

3.  Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.

Authors:  Jiansheng Huang; Yuzhi Jia; Tao Fu; Navin Viswakarma; Liang Bai; M Sambasiva Rao; Yijun Zhu; Jayme Borensztajn; Janardan K Reddy
Journal:  FASEB J       Date:  2011-10-18       Impact factor: 5.191

4.  Expression of base excision DNA repair genes as a biomarker of oxidative DNA damage.

Authors:  Christine L Powell; James A Swenberg; Ivan Rusyn
Journal:  Cancer Lett       Date:  2005-01-08       Impact factor: 8.679

5.  A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection.

Authors:  S Melnyk; M Pogribna; I Pogribny; R J Hine; S J James
Journal:  J Nutr Biochem       Date:  1999-08       Impact factor: 6.048

6.  PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo.

Authors:  Kathrin Klein; Maria Thomas; Stefan Winter; Andreas K Nussler; Mikko Niemi; Matthias Schwab; Ulrich M Zanger
Journal:  Clin Pharmacol Ther       Date:  2012-06       Impact factor: 6.875

7.  Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet.

Authors:  Igor P Pogribny; Volodymyr P Tryndyak; Tetyana V Bagnyukova; Stepan Melnyk; Beverly Montgomery; Sharon A Ross; John R Latendresse; Ivan Rusyn; Frederick A Beland
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

Review 8.  Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

Authors:  Fabio Marra; Amalia Gastaldelli; Gianluca Svegliati Baroni; Gianluca Tell; Claudio Tiribelli
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

9.  Subspecific origin and haplotype diversity in the laboratory mouse.

Authors:  Hyuna Yang; Jeremy R Wang; John P Didion; Ryan J Buus; Timothy A Bell; Catherine E Welsh; François Bonhomme; Alex Hon-Tsen Yu; Michael W Nachman; Jaroslav Pialek; Priscilla Tucker; Pierre Boursot; Leonard McMillan; Gary A Churchill; Fernando Pardo-Manuel de Villena
Journal:  Nat Genet       Date:  2011-05-29       Impact factor: 38.330

10.  Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice.

Authors:  Ravi J Tolwani; Doug A Hamm; Liqun Tian; J Daniel Sharer; Jerry Vockley; Piero Rinaldo; Dietrich Matern; Trenton R Schoeb; Philip A Wood
Journal:  PLoS Genet       Date:  2005-08-19       Impact factor: 5.917

View more
  16 in total

Review 1.  Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart.

Authors:  Jean-Louis Guéant; Rania Elakoum; Olivier Ziegler; David Coelho; Eva Feigerlova; Jean-Luc Daval; Rosa-Maria Guéant-Rodriguez
Journal:  Pflugers Arch       Date:  2013-09-03       Impact factor: 3.657

2.  Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.

Authors:  Ramy El-Diwany; Lisa N Wasilewski; Kenneth W Witwer; Justin R Bailey; Kimberly Page; Stuart C Ray; Andrea L Cox; David L Thomas; Ashwin Balagopal
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

Review 3.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

4.  Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Igor P Pogribny; Kostiantyn Dreval; Iryna Kindrat; Stepan Melnyk; Leandro Jimenez; Aline de Conti; Volodymyr Tryndyak; Marta Pogribna; Juliana Festa Ortega; S Jill James; Ivan Rusyn; Frederick A Beland
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

Review 5.  Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.

Authors:  Kristen Stephenson; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Gianfranco Alpini; Heather Francis
Journal:  Gene Expr       Date:  2017-11-02

6.  Nonalcoholic Fatty Liver Disease Is a Susceptibility Factor for Perchloroethylene-Induced Liver Effects in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Yu-Syuan Luo; Yasuhiro Iwata; Kranti Konganti; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

7.  A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer.

Authors:  Takuma Tsuchida; Youngmin A Lee; Naoto Fujiwara; Maria Ybanez; Brittany Allen; Sebastiao Martins; M Isabel Fiel; Nicolas Goossens; Hsin-I Chou; Yujin Hoshida; Scott L Friedman
Journal:  J Hepatol       Date:  2018-03-21       Impact factor: 30.083

8.  Effects of Choline on Meat Quality and Intramuscular Fat in Intrauterine Growth Retardation Pigs.

Authors:  Bo Li; Wei Li; Hussain Ahmad; Lili Zhang; Chao Wang; Tian Wang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease.

Authors:  Yan Fan; Long-Teng Yan; Zheng Yao; Guang-Yi Xiong
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-09       Impact factor: 3.168

Review 10.  Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.

Authors:  Jesse D Riordan; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2014-05-07       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.